Viewing Study NCT05633420


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-01-25 @ 3:25 AM
Study NCT ID: NCT05633420
Status: COMPLETED
Last Update Posted: 2022-12-02
First Post: 2022-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
Sponsor: Shin Poong Pharmaceutical Co. Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pyramax View
None pyronaridine-artesunate View
None COVID-19 View
None SARS-CoV-2 View